homovanillic acid has been researched along with Encephalopathy, Toxic in 8 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Male Sprague-Dawley (SD) rats were dosed orally with ACR at 0 (saline), 20, 30, and 40 mg/kg/day for 20 days." | 1.42 | Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system. ( Cheng, G; Guo, X; Lu, Q; Pan, X; Xiong, F; Yan, H, 2015) |
| "5Gy) TBI, C57BL/6 mice were administered with MPTP (15mg/kg, four times, 2h apart) intraperitoneally (i." | 1.35 | Potential mechanisms of neuroprotection induced by low dose total-body gamma-irradiation in C57 mice administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( Guo, Q; Li, S; Liang, Y; Su, B; Wen, C; Zhang, Y, 2009) |
| " Although increasing the dosage of d-METH (20 to 80 mg/kg) did increase the GFAP response (100% over control), it was still well below that usually exhibited at the usual neurotoxic dosage (300-400% over control) in fully mature mice." | 1.31 | Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. ( Ali, SF; Miller, DB; O'Callaghan, JP, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miner, NB | 1 |
| Elmore, JS | 1 |
| Baumann, MH | 1 |
| Phillips, TJ | 1 |
| Janowsky, A | 1 |
| Pan, X | 1 |
| Guo, X | 1 |
| Xiong, F | 1 |
| Cheng, G | 1 |
| Lu, Q | 1 |
| Yan, H | 1 |
| Zhang, Y | 1 |
| Li, S | 1 |
| Liang, Y | 1 |
| Wen, C | 1 |
| Guo, Q | 1 |
| Su, B | 1 |
| Bradner, JM | 1 |
| Suragh, TA | 1 |
| Wilson, WW | 1 |
| Lazo, CR | 1 |
| Stout, KA | 1 |
| Kim, HM | 1 |
| Wang, MZ | 1 |
| Walker, DI | 1 |
| Pennell, KD | 1 |
| Richardson, JR | 1 |
| Miller, GW | 1 |
| Caudle, WM | 1 |
| Tanaka, K | 1 |
| Ogawa, N | 1 |
| Kita, T | 1 |
| Matsunari, Y | 1 |
| Saraya, T | 1 |
| Shimada, K | 1 |
| O'Hara, K | 1 |
| Kubo, K | 1 |
| Wagner, GC | 1 |
| Nakashima, T | 1 |
| Imam, SZ | 1 |
| Islam, F | 1 |
| Itzhak, Y | 1 |
| Slikker, W | 1 |
| Ali, SF | 2 |
| Miller, DB | 1 |
| O'Callaghan, JP | 1 |
8 other studies available for homovanillic acid and Encephalopathy, Toxic
| Article | Year |
|---|---|
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Temperature Regulation; Brain; Ce | 2017 |
Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acrylamide; Administration, Oral; Animals; Corpus Striatum; Dopamine | 2015 |
Potential mechanisms of neuroprotection induced by low dose total-body gamma-irradiation in C57 mice administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chroma | 2009 |
Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Cell Count; Cells, Cultured; Chromato | 2013 |
Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Cabergoline; Carbidopa; Caspases; Dis | 2005 |
Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Tempe | 2000 |
Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; | 2000 |
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Area Under Curve; Body Temperature; Central Nervous | 2000 |